These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 6834852

  • 1. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G, Canal P, Mockey E, Vandevoorde E, Laurent F, Soula G.
    J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
    [Abstract] [Full Text] [Related]

  • 2. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
    Akel G, Canal P, Bugat R, Soula G, Combes PF.
    J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
    [Abstract] [Full Text] [Related]

  • 3. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.
    McManus ME, Monks A, Collins JM, White R, Strong JM.
    J Pharmacol Exp Ther; 1981 Dec; 219(3):669-74. PubMed ID: 7299690
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
    Workman P.
    Cancer Clin Trials; 1980 Dec; 3(3):237-51. PubMed ID: 7438321
    [Abstract] [Full Text] [Related]

  • 5. The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
    Dische S, Saunders MI, Riley PJ, Hauck J, Bennett MH, Stratford MR, Minchinton AI.
    Br J Cancer; 1981 Mar; 43(3):344-9. PubMed ID: 7225285
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.
    Flockhart IR, Large P, Troup D, Malcolm SL, Marten TR.
    Xenobiotica; 1978 Feb; 8(2):97-105. PubMed ID: 415443
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
    White RA, Workman P.
    Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
    Gianni L, Jenkins JF, Greene RF, Lichter AS, Myers CE, Collins JM.
    Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
    [Abstract] [Full Text] [Related]

  • 9. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
    Blasberg R, Horowitz M, Strong J, Molnar P, Patlak C, Owens E, Fenstermacher J.
    Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636
    [Abstract] [Full Text] [Related]

  • 10. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
    White R, Workman P, Owen L.
    Int J Radiat Oncol Biol Phys; 1982 Apr; 8(3-4):473-6. PubMed ID: 7107369
    [Abstract] [Full Text] [Related]

  • 11. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
    Horowitz M, Blasberg R, Molnar P, Strong J, Kornblith P, Pleasants R, Fenstermacher J.
    Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144
    [Abstract] [Full Text] [Related]

  • 12. Morphological changes in rat hepatocytes in primary culture induced by Misonidazole, desmethylmisonidazole and Ro 03-8799.
    Smith RA.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984 Aug; 46(1-2):65-76. PubMed ID: 6147929
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
    Brown JM, Yu NY, Workman P.
    Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
    [Abstract] [Full Text] [Related]

  • 14. Desmethylmisonidazole (Ro 05-9963): clinical pharmacokinetics after multiple oral administration.
    Stratford MR, Minchinton AI, Dische S, Saunders MI, Anderson P.
    Int J Radiat Oncol Biol Phys; 1982 Mar; 8(3-4):377-9. PubMed ID: 7107355
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD, Baer K, Lee J.
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [Abstract] [Full Text] [Related]

  • 16. The penetration of misonidazole into a mature structural cartilage.
    Langler AJ, Bugden RD, Gibson P.
    Br J Cancer; 1982 Feb; 45(2):282-5. PubMed ID: 7059476
    [Abstract] [Full Text] [Related]

  • 17. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
    Rasey JS, Grunbaum Z, Krohn K, Nelson N, Chin L.
    Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
    [Abstract] [Full Text] [Related]

  • 18. Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.
    Akel G, Benard P, Canal P, Soula G.
    Cancer Chemother Pharmacol; 1986 Mar; 17(2):121-6. PubMed ID: 3719893
    [Abstract] [Full Text] [Related]

  • 19. Cellular uptake of misonidazole and analogues with acidic or basic functions.
    Dennis MF, Stratford MR, Wardman P, Watts ME.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):629-43. PubMed ID: 3873433
    [Abstract] [Full Text] [Related]

  • 20. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K, Takahashi M, Nishidai T, Dodo Y, Shibamoto Y, Hiraoka M, Yukawa Y, Abe M.
    Radiat Med; 1984 Jun; 2(1):71-5. PubMed ID: 6242712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.